What's Going On With Capricor Therapeutics Stock On Friday? - Capricor Therapeutics (NASDAQ:CAPR)

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its Duchenne muscular dystrophy therapy.

Raccontata dabenzinga.com